The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer

M Heger, RF van Golen, M Broekgaarden… - Pharmacological …, 2014 - ASPET
This review addresses the oncopharmacological properties of curcumin at the molecular
level. First, the interactions between curcumin and its molecular targets are addressed on …

Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways

AH Rahmani, MA Al Zohairy, SM Aly… - BioMed research …, 2014 - Wiley Online Library
Cancer is the most dreadful disease worldwide in terms of morbidity and mortality. The exact
cause of cancer development and progression is not fully known. But it is thought that cancer …

A novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer

S Taurin, H Nehoff, T Van Aswegen… - BioMed Research …, 2014 - Wiley Online Library
Of patients with castrate resistant prostate cancer (CRPC), less than 25–33% survive more
than five years. Recent studies have implicated estrogen, acting either alone or …

Synthesis and evaluation of curcumin-related compounds containing inden-2-one for their effects on human cancer cells

D Zhou, N Ding, S Zhao, D Li, J Van Doren… - Biological and …, 2014 - jstage.jst.go.jp
Indanones are very useful molecules as starting building blocks for the synthesis of
biologically active compounds. A series of novel curcumin-related compounds containing …

[PDF][PDF] Curcumin Analogues for the Treatment of Breast Cancer Revisited: The Nanotechnology Approach

V Sundararajan, RJ Rosengren… - … Science: Hauppauge, NY …, 2014 - researchgate.net
Curcumin, the principal active component of turmeric, has anti-cancer and antiinflammatory
properties and is effective in animal models of cancers such as prostate and colon …